$ACMR

Wang David H sold $1.5M of ACMR

Wang David H (See Remarks) sold 17,543 shares of ACM Research, Inc. (ACMR) at $85.11 ($1.49M total) on 2026-06-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Wang David H
Published Jun 5, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 5, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ACMR
Neutral
medium confidence
Mentioned
$ACMR
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ACMRNeutralLow
01

Why it matters

The disclosure updates insider ownership records and may slightly influence sentiment, but it is not a fundamental catalyst given the pre-arranged 10b5-1 plan.

02

Market read

Traders may treat it as low-signal sentiment data rather than a standalone driver of price.

03

What to watch

The article provides only the sale size and plan flag; it does not indicate whether other insiders or institutions are buying, nor any concurrent news.

Relevance 6/10Novelty 3/10Timing: Filed today; sale executed 2026-06-04.

Background

This is an SEC Form 4 insider transaction disclosure for an officer/director/10% owner of ACM Research.

Company-level read

Ticker impact

$ACMRNeutralMedium confidence
Context

ACM Research insider Wang David H sold $1.49M of ACMR shares via an open-market transaction under a 10b5-1 plan.

Expected impact

Likely limited near-term impact; any effect is more about sentiment/positioning than fundamentals.

Evidence & confidence

Form 4 shows a scheduled sale (10b5-1), with no accompanying operational or financial catalyst in the article.

Market effects

Minimal—this is company-specific insider activity without sector-wide information.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider sales can still coincide with valuation/positioning concerns; traders may watch for follow-on selling.

Key entities

  • ACM Research, Inc.

    Subject of the Form 4 insider sale disclosure.

  • Wang David H

    Officer/Director/10% Owner who sold 17,543 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ACMRMed

AI Sovereignty Becomes a New National Security Battleground: Morgan Stanley Names SpaceX and 4 Other Beneficiary Stocks, with Upside Potential Topping 100% — BigGo Finance

Morgan Stanley identifies SpaceX, ACM Research, Amkor Technology, Alibaba, and KLA as key beneficiaries of the AI sovereignty trend. The bank assigns price targets with upside potential ranging from 21% to 105%, highlighting the strategic importance of AI infrastructure for national security and economic competitiveness.

$ACMRMed

ACM Research (NASDAQ: ACMR) unit’s orders surge past 100% with 42–48% margin outlook

ACM Research (Shanghai) reported a 105% year-over-year increase in new orders for the first half of 2026, with growth across electroplating, cleaning, and advanced packaging equipment. The company expects gross margins to remain between 42% and 48%. Significant orders include panel-level electroplating systems for delivery in 2026 and 2027. ACM Shanghai also highlighted rapid growth in mature-node semiconductor manufacturing and AI-related equipment demand.

$ACMRMedAI 9/10

ACM Research (ACMR) Q2 2026 Earnings Call Transcript

ACM Research (ACMR) reported Q2 2026 revenue of $292.9M, up 36% year over year, with non-GAAP diluted EPS of $0.61. Non-GAAP gross margin was 46.0%. The company raised 2026 revenue guidance to $1.125B-$1.175B and said first-half orders rose 105%. Net cash was $1.0B.